Inhibitors | Comment | Organism | Structure |
---|---|---|---|
leupeptin | - |
Rattus norvegicus | |
additional information | chloroquine; EDTA; Nalpha-p-tosyl-L-lysine chloromethylketone hydrochloride; not: diisopropyl fluorophosphate | Rattus norvegicus | |
PCMB | - |
Rattus norvegicus | |
pepstatin A | - |
Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Rattus norvegicus | 16020 | - |
soluble | - |
Rattus norvegicus | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hypophysis | intermediate | Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Pro-opiomelanocortin + H2O | - |
Rattus norvegicus | Adrenocorticotropin + beta-lipotropin | + alpha-melanotropin MW 16000 + NH2-terminal glycopeptide + an endorphin-related peptide | ? | |
Pro-opiomelanocortin + H2O | - |
Rattus norvegicus | Adrenocorticotropin + beta-lipotropin | ACTH of MW 21000 and 13000 | ? |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
5 | - |
crude enzyme extract | Rattus norvegicus |